Profile
ABVX NVO VRTX REGN MRNA SGEN
Company Name Abivax SA American Depositary Shares Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $843.09M $643.34B $121.61B $114.55B $44.44B $43.15B
Employees 0.06K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Marc M. P. de Garidel M.B.A. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABVX NVO VRTX REGN MRNA SGEN
Quant Rating Score 3 5 4 4 3 3
Quant Rating Neutral Strong Buy Buy Buy Neutral Neutral
Trading
ABVX NVO VRTX REGN MRNA SGEN
Last Close $13.56 $145.42 $471.25 $1057.02 $115.95 $228.74
High 52 $15.89 $199.54 $485.53 $1071.19 $166.61 $228.9
Low 52 $8.1 $87.78 $338.18 $692.45 $69.51 $191.51
Price vs. 52 Week High -14.66 % -27.12 % -2.94 % -1.32 % -30.41 % -0.07 %
Price vs. 52 Week Low 67.41 % 65.66 % 39.35 % 52.65 % 66.81 % 19.44 %
Total Return
ABVX NVO VRTX REGN MRNA SGEN
1 Month Return -3.14 % 7.5 % 3.49 % 7.84 % -18.66 % 0 %
3 Month Return -3.42 % 14.99 % 15.1 % 10.72 % 11.91 % 0 %
6 Month Return 26.85 % 42.39 % 14.68 % 16.8 % 3.07 % 0 %
9 Month Return 0 % 58.41 % 35.48 % 29.22 % 12.24 % 8.03 %
YTD Return 26.73 % 40.57 % 15.82 % 20.35 % 16.59 % 0 %
1 Year Return 0 % -10.14 % 33.91 % 47.11 % -4.57 % 18.85 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.14 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -375.97 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ABVX NVO VRTX REGN MRNA SGEN
Asset Growth 345.88 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -12.5 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 0.83 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year 2336.82 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year 5965.58 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year 1228.76 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -133.02 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -111.52 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -30.71 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -120.61 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -439.7 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -133.02 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -257.32 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -11.41 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -61.81 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG - 150.92 % 6084.35 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -9.58 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -9.58 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share 1066.55 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 263.79 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 33.64 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 24.05 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 20.4 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -257.72 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABVX NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM - 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -45.17 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -106.86 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -51.36 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 97.05 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 115.33 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM - 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -180.84 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.03 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM 707000 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM - 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM - 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -2.07 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -2.08 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 540.46 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM - 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.27 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -180.84 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -7.83 88.98 34.95 28.82 -12.1 -61.54
Price To Operating Cash Flows Ratio TTM -6.02 48.3 30.85 24.04 -15.37 -79.67
Price Cash Flow Ratio TTM -6.02 48.3 30.85 24.04 -15.37 -79.67
Income Statement (TTM)
ABVX NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 84.7% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.13B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.15B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -3.43 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABVX NVO VRTX REGN MRNA SGEN
Long Term Debt $0.04B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.13B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.2B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.02B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.06B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.33B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABVX NVO VRTX REGN MRNA SGEN
Net Income $-0.15B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.1B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.32
ABCL AbCellera Biologics Inc. 2.765
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.11
ABIO ARCA biopharma, Inc. 3.76
ABOS Acumen Pharmaceuticals, Inc. 2.26
ABSI Absci Corporation 2.97
ABUS Arbutus Biopharma Corporation 3.13
ABVC ABVC BioPharma, Inc. 0.753
ACAD ACADIA Pharmaceuticals Inc. 15.84
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.1
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.802
ACHV Achieve Life Sciences, Inc. 4.6
ACIU AC Immune SA 3.87
ACLX Arcellx, Inc. 53.25
ACRV Acrivon Therapeutics, Inc. Common Stock 6.1
ACST Acasti Pharma Inc. 2.825
ACXP Acurx Pharmaceuticals, Inc. 2.1601
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0.00619459 45.811
BOUT Innovator IBD Breakout Opportunities ETF 2.56 34.8455
SPEU SPDR Portfolio Europe ETF 0.003132 41.89
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 273.95
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0865 23172.5
Unlock